Prostate News Archive
22-Jan-2011
Prostate-shrinking drug may help detect cancer
Study finds that men who used medication received more accurate readings on their prostate specific antigen tests. Researchers believe driver mutations extremely promote development, growth of prostate cancer
prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications. MicroRNA suppresses prostate cancer stem cells and metastasis
A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. miR-34a targets a surface protein common to cancer stem cells and associated with tumor development and metastasis. When the micro RNA stifles CD44, it inhibits formation of prostate stem cells. Researchers blocked tumor formation, shrunk tumors and inhibited ... Prostate cancer support group meeting at the Church of Presentation
LifeLines, a supportive and informative resource for prostate cancer patients and their partners in Northern Bergen County, will meet from 7:30 to 9 p.m. on Tuesday, Jan. 25, at the Church of the Presentation, 271 W. Saddle River Road, in Upper Saddle River. The group was formed by prostate cancer patients to share information and experience about available treatment and service resources. Uncovering the genetics of prostate cancer
( Helmholtz Association of German Research Centres ) Germany will contribute another project to the International Cancer Genome Consortium. Coordinated by the German Cancer Research Center and the University Medical Center Hamburg-Eppendorf, physicians and molecular biologists will now start to investigate the genetic causes of early prostate cancer. The German Ministry of Research and Education ...
Back to Prostate News Archive
